Scientists investigate CD56 Protein's role in blood cancers
NCT ID NCT04546945
First seen Apr 03, 2026 · Last updated May 14, 2026 · Updated 6 times
Summary
This study aims to understand how a protein called CD56 appears in different blood cancers, such as multiple myeloma and acute myeloid leukemia. Researchers will analyze blood or bone marrow samples from 38 newly diagnosed patients to see how common CD56 is and whether it relates to patient outcomes. The goal is to gather knowledge that may help guide future treatments.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEMATOLOGIC MALIGNANCIES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Assiut University
COMPLETEDAsyut, Egypt
-
Assiut university
RECRUITINGAsyut, Egypt
Contact
Conditions
Explore the condition pages connected to this study.